This Journal of Hematology & Oncology series calls for clinical studies on novel agents for cancers and blood disorders. Summaries and reviews on first-in-human or first-in-class studies are also welcome.
To submit, please visit the journal's editorial management system.
Articles published in the collection have already gone through the systematic peer review process of the journal.